Table 2.

Patient characteristics (n = 122)

Patient parameter	Value
Median age (years; range)	71.5 (50.9–83.3)
Gleason score, n (%)
Low risk (2–6)	50 (41%)
Intermediate risk (7)	48 (39.3%)
High risk (8–10)	23 (18.9%)
Serum PSA (ng/ml), n (%)
Low risk (<10)	52 (42.6%)
Intermediate risk (10–20)	38 (31.1%)
High risk (>20)	32 (26.2%)
Initial tumor stage (clinical examination and CT), n (%)
Low risk (T1–2a)	53 (43.4%)
Intermediate risk (T2b-c)	44 (36.1%)
High risk: extracapsular extension (T3a)	21 (17.2%)
High risk: seminal vesicle infiltration (T3b)	4 (3.3%)